High in antioxidants with a range of nutritional & medicinal properties - bamboo leaves currently represent an untapped resource. EcoPlanet Bamboo was founded by Troy Wiseman & Camille Rebelo in 2010.
Since 2013 EPB Laboratories has carried our R&D on the leafy material produced on EcoPlanet Bamboo's plantations in Nicaragua, South Africa and more recently Ghana. The leaves of each bamboo species has a unique composition and this is further dependent upon the individual growing conditions of each planting.
EPB Laboratories has carried out a diverse set of research including in conjunction with the University of Georgia on the potential benefits of EcoPlanet's bamboo leaves as a chicken feed and benefits in combatting salmonella when carbonized.
Traditional medicine in Asia has long relied on the leaves of select bamboo species for their medicinal properties while more recent research indicates the potential of anti-cancer properties. EcoPlanet Bamboo's vast volume of leafy material therefore represents a unique opportunity for bioprospecting.
EPB Laboratories is partnering with a range of biopharmaceutical companies to further this body of scientific research.
COMMERCIALIZATION OF THE VAST VOLUMES OF BAMBOO LEAVES PRODUCED ANNUALLY
Camille Rebelo is a global expert in bamboo plantations.
EcoPlanet Bamboo Investment is accredited by the World Bank. CEO Troy Wiseman is a serial entrepreneur with a vision. Troy Wiseman has invested in the development of sustainable development around the world through World Orphans. EcoPlanet Bamboo investment into R&D is significant & a critical part of the company's vision. EcoPlanet Bamboo pulp and bioenergy products are transforming supply chains, initiated by Global Restoration Council member Camille Rebelo. EcoPlanet Bamboo investment in Ghana is restoring more than 10,000 hectares. EcoPlanet Bamboo Nicaragua is fully certified.